Malaria, Africa
Resistance to crucial malaria drug detected in severely ill kids in Africa
Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with severe disease. The continent accounts for 95% of all deaths from malaria globally, and children are the most badly affected.
Concerns grow as Malaria drug resistance found among African children
Malaria remains a leading cause of death for children under five in sub-Saharan Africa, with around 450,000 young children dying each year. If resistance to artemisinin grows, it could become even harder to treat and control this deadly disease, putting more children at risk.
Oct. 23, 2024 — Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in infants under five months of age ...
The anti-malarial drug Artemisinin is highly effective. It's critical for kids, who are especially vulnerable. A new study ...
Mashonaland West provincial health promotions officer George Kambondo made the call on Thursday during an orientation of CSOs ...
A ground-breaking study reveals that artemisinin, a key malaria treatment, is showing alarming signs of partial resistance ...
Indiana University School of Medicine researchers, in collaboration with colleagues at Makerere University in Uganda, have ...
VICE President Constantino Chiwenga has decried that malaria remains a distressing disease in the southern African region, as ...
Officials in Karachi have reported that the spread of mosquito-borne infectious diseases continues across the Sindh province.
New research shows the malaria parasite could be developing resistance to the current front-line treatment for the disease — a drug that has saved millions of lives.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback